Asian Manufacturing Activity Stumbles Again Under Weight of Trump Tariffs
Factory activity slowed across much of Asia in May as uncertainty over U.S. tariffs continued to cause steep declines in new orders, purchasing managers surveys show.
The latest set of S&P Global purchasing managers indexes showed another pullback in manufacturing last month amid trade policy worries and subdued demand.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Stock market today: Dow, S&P 500, Nasdaq futures waver as Trump tariffs test Wall Street optimism
US stock futures drifted up as Wall Street largely shrugged off tariff risks even as President Trump doubled duties on steel and aluminum imports. Futures attached to the Dow Jones Industrial Average (YM=F), the benchmark S&P 500 (ES=F), and the tech-heavy Nasdaq 100 (NQ=F) rose 0.1%. Trump signed a proclamation on Tuesday evening that hiked tariffs on steel and aluminum imports from 25% to 50%. The United Kingdom is the only country exempt from the increase. The president's latest tariff move comes amid escalating tensions between the US and key trading partners China and the European Union. Read more: The latest on Trump's tariffs During the day on Tuesday, stocks extended Monday's gains as an unexpectedly upbeat April JOLTS report and Nvidia's (NVDA) stock rally lifted investor hopes that the economy can weather the impact of Trump's trade policy. Wall Street will get another pulse check on the labor market with the release of ADP employment data on Wednesday. The main event lands on Friday with the closely watched May jobs report.
Android Authority
an hour ago
- Android Authority
Samsung announces an Ultra-branded foldable is coming — Galaxy Z Fold Ultra?
Over the years, Samsung's foldable phone launches have been very reliable. We see two phones at each launch: a book-style Galaxy Z Fold and a clamshell-style Galaxy Z Flip. However, it looks like the formula could change in 2025. This is due to Samsung just announcing an Ultra-branded book-style foldable is coming this summer.
Yahoo
an hour ago
- Yahoo
HealthEquity (HQY) Surpasses Q1 Earnings and Revenue Estimates
HealthEquity (HQY) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.80 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 19.75%. A quarter ago, it was expected that this provider of services for managing health care accounts would post earnings of $0.71 per share when it actually produced earnings of $0.69, delivering a surprise of -2.82%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. HealthEquity , which belongs to the Zacks Medical Services industry, posted revenues of $330.84 million for the quarter ended April 2025, surpassing the Zacks Consensus Estimate by 3.03%. This compares to year-ago revenues of $287.6 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. HealthEquity shares have added about 7.2% since the beginning of the year versus the S&P 500's gain of 0.9%. While HealthEquity has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for HealthEquity: favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.88 on $319.33 million in revenues for the coming quarter and $3.60 on $1.3 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical Services is currently in the top 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, PACS Group, Inc. (PACS), is yet to report results for the quarter ended March 2025. This company is expected to post quarterly earnings of $0.42 per share in its upcoming report, which represents a year-over-year change of +10.5%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. PACS Group, Inc.'s revenues are expected to be $1.09 billion, up 16.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY) : Free Stock Analysis Report PACS Group, Inc. (PACS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
